Skip to main content
. 2021 Feb 3;13(4):590. doi: 10.3390/cancers13040590

Table 1.

Patient Characteristics.

Characteristic Total Number of Patients Medicare
N (%), Median [Range]
Private Insurance
N (%), Median [Range]
Medicaid
N (%), Median [Range]
Not insured
N (%), Median [Range]
Other gov. ins.
N (%), Median [Range]
Total Number 115,099 62,340 (53) 41,340 (35) 6410 (5.4) 3796 (3.2) 1213 (1)
Age at diagnosis 67 (19–90) 74 (23–90) 57 (21–90) 58 (19–90) 57 (21–90) 61 (27–90)
Gender
Male 62,798 (55) 33,071 (53) 23,438 (57) 3338 (52) 2155 (57) 796 (66)
Female 52,301(45) 29,269 (47) 17,902 (43) 3072 (48) 1641 (43) 417 (34)
Race
White 87,263 (77) 49,313 (79) 31,472 (76) 3446 (54) 2214 (58) 818 (67)
Black 22,976 (20) 10,982 (18) 7910 (19) 2432 (38) 1347 (35) 305 (25)
Other 3616 (3) 1489 (2) 1416 (3) 449 (7) 193 (5) 69 (6)
Median income (zip-code-based) *
<30 k 16,419 (15) 9178 (15) 4497 (11) 1712 (27) 858 (23) 174 (14)
30–34.9 k 19,878 (18) 11,258 (18) 6341 (15) 1258 (20) 784 (21) 237 (20)
35–45.9 k 30,160 (27) 16,717 (27) 10,394 (25) 1687 (26) 951 (25) 411 (34)
≥46 k 44,367 (40) 23,000 (37) 18,419 (45) 1567 (24) 1044 (28) 337 (28)
Education level (zip-code-based) ^
Level 1 20,276 (18) 10,731 (17) 6021 (15) 2156 (34) 1175 (31) 193 (16)
Level 2 25,513 (23) 14,000 (22) 8546 (21) 1700 (27) 997 (26) 270 (22)
Level 3 25,223 (23) 14,011 (22) 9054 (22) 1215 (19) 623 (16) 320 (26)
Level 4 39,807 (36) 21,410 (34) 16,026 (39) 1153 (18) 842 (22) 376 (31)
Area of residence
Metro 92,236 (83) 48,638 (78) 34,110 (83) 5437 (85) 3147 (83) 904 (75)
Urban 16,795 (15) 10,172 (16) 5159 (12) 739 (12) 485 (13) 240 (20)
Rural 2357 (2) 1502 (2) 689 (2) 83 (1) 55 (1) 28 (2)
Facility location
Northeast 24,688 (22) 13,135 (21) 9466 (23) 1560 (24) 459 (12) 68 (6)
Midwest 29,936 (26) 17,379 (28) 10,342 (25) 1331 (21) 678 (18) 206 (17)
West 18,113 (16) 9032 (14) 7071 (17) 1252 (20) 482 (13) 276 (23)
South 40,834 (36) 22,722 (36) 13,479 (33) 1950 (30) 2036 (54) 647 (53)
Disease
Primary 97,693 (65) 49,969 (80) 37,167 (90) 5929 (92) 3564 (94) 1064 (88)
Secondary 17,394 (15) 12,366 (20) 4167 (10) 481 (8) 231 (6) 149 (12)
Durie–Salmon Stage
1 2118 (1.8) 954 (2) 1010 (2) 92 (1) 36 (1) 26 (2)
2 2970 (2.5) 1371 (2) 1326 (3) 152 (2) 85 (2) 36 (3)
3 7502 (6.4) 3297 (5) 3334 (8) 518 (8) 258 (7) 95 (8)
Not available 105,336 (89.3) 56,718 (91) 35,670 (87) 5648 (89) 3417 (90) 1056 (87)
Charlson/Deyo comorbidity score
0 87,121 (76) 44,534 (71) 33,963 (82) 4683 (73) 2998 (79) 943 (78)
1 18,799 (16) 11,626 (19) 5347 (13) 1110 (17) 538 (14) 178 (15)
2 6405 (6) 4303 (7) 1477 (4) 403 (6) 158 (4) 64 (5)
3 or more 2774 (2) 1877 (3) 553 (1) 214 (3) 102 (3) 28 (2)
Hematopoietic stem cell transplant
Yes 18,213 (16) 4651 (7) 11,942 (29) 1075 (17) 272 (7) 273 (23)
No 94,354 (84) 56,606 (91) 28,244 (68) 5175 (81) 3414 (90) 915 (75)
Facility type £
Community 10,460 (9) 6789 (11) 2713 (7) 573 (9) 270 (7) 115 (9)
Comprehensive community 45,428 (40) 28,007 (45) 13,962 (34) 1687 (26) 1292 (34) 480 (40)
Academic 45,990 (41) 20,791 (33) 19,834 (48) 3190 (50) 1677 (44) 498 (41)
Integrated network cancer program 11,693 (10) 6681 (11) 3849 (9) 643 (10) 416 (11) 104 (9)
Facility volume
<10 patient/year 44,040 (38) 27,113 (43) 12,697 (31) 2271 (35) 1538 (41) 421 (35)
10–50 patient/year 55,648 (48) 29,354 (47) 20,390 (49) 3287 (51) 1978 (52) 639 (53)
>50 patient/year 15,411 (14) 5873 (9) 8253 (20) 852 (13) 280 (7) 153 (13)
Distance traveled
Distance traveled (miles) 10 (0–4961) 8 (0–4961) 12 (0–3367) 7 (0–2439) 9 (0–2424) 14 (0–3329)
Traveled > 120 miles 4711 (4) 1964 (3) 2384 (5.7) 184 (2.8) 97 (2.4) 82 (6.7)

* <46 k vs. >46 k; ^ Level 1: >29%, level 2: 20–28.9%, level 3: 14–19.9%, level 4: <14%; £ was categorized as comprehensive community cancer program (500 or more new cancer cases per year), community cancer program (100–500 new cancer cases per year), integrated network cancer program (part of a network that offers comprehensive services), and academic comprehensive cancer program (more than 500 new cancer cases per year).